We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Arexvy
Australian Public Assessment Report
Device/Product Name
Arexvy
Active ingredients
Recombinant respiratory syncytial virus pre-fusion F protein
AusPAR Date
Published
Submission Number
PM-2022-05281-1-2
Submission Type
New Biological Entity (New Vaccine)
Decision
Approved